Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet
All four studies met their primary endpoints, showing that people treated with Faricimab up to every four months achieved…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Faricimab
Roche Pharma achieves several milestones in Q3
The company announced several key development milestones in neuroscience, ophthalmology, oncology and COVID-19, along with some…
FDA accepts application for Roche’s Faricimab
If approved, Faricimab would be the first and only medicine designed to target two distinct pathways that drive retinal diseases…